Universal Health Realty Income (UHT) AI Stock Analysis

• Market Cap: $604.33M
• Dividend Yield: 7.51%
• Average Volume (3M): 58.65K
• Price to Earnings (P/E): 33.6
• Beta (1Y): 0.39
• Revenue Growth: 0.68%
• EPS Growth: -1.34%
• Country: US
• Employees: N/A
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.31
• Shares Outstanding: 13,873,618
• 10 Day Avg. Volume: 47,497
• 30 Day Avg. Volume: 58,653
• PEG Ratio: -3.56
• Price to Book (P/B): 3.56
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 11.04
• Enterprise Value/Market Cap: 1.00
• Enterprise Value/Revenue: 4.07
• Enterprise Value/Gross Profit: 4.31
• Enterprise Value/Ebitda: 7.05
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.73
• Revenue Forecast (FY): $102.30M

• Rating: 64 Neutral
• Price Target: $47.00 ▲(14.44% Upside)
• Action: Reiterated Date: 02/26/26
• Date: Action: Reiterated 02/26/26

The score is driven primarily by steady cash generation and solid profitability, partially offset by high leverage and data anomalies that cloud the latest-year financial trend. Technicals add support via an established uptrend, while valuation is mixed—strong yield but a high P/E.

Positive Factors

Consistent cash generation

Steady operating cash flow and strong free cash flow indicate durable internal funding for dividends, maintenance, and selective reinvestment. For a healthcare REIT, reliable FCF supports payout sustainability and reduces reliance on external capital over a multi-month to multi-year horizon.

High and stable margins with revenue growth

Strong gross margins and multi-year revenue growth reflect a landlord model with net leases and low property-level operating expense exposure. Stable profitability margins underpin consistent cash available for FFO and dividends, supporting long-term income generation for investors.

Predictable healthcare REIT business model

A focused portfolio of healthcare properties and long-term net leases creates predictable contractual rent streams. The structural demand for medical facilities and long lease terms provide durable occupancy and cash flow resilience across healthcare cycles over months to years.

Negative Factors

Elevated leverage

Meaningful leverage limits financial flexibility and raises refinancing and interest-rate risk for a capital-intensive REIT. With modest cash-flow coverage metrics, higher funding costs or stressed tenant payments could constrain dividends or capital activity over the coming months.

Tenant concentration risk

Concentration with a single large operator creates material revenue risk: adverse performance, renegotiation, or operator distress would disproportionately impact rental income and occupancy. This dependency reduces diversification resilience over a multi-month to multi-year horizon.

2025 data anomalies cloud trends

Inconsistent 2025 reporting (zeroed revenue/margins) impairs trend visibility and forecasting. For investors, unclear latest-year data increases uncertainty about recent performance, complicates capital planning, and weakens confidence in multi-month fundamental assessments.

Universal Health Realty Income Business Overview & Revenue Model

Company Description

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.

How the Company Makes Money

Universal Health Realty Income Trust generates revenue primarily through long-term leases of its healthcare properties. The company typically enters into net lease agreements, where tenants are responsible for property expenses such as taxes, insurance, and maintenance, allowing UHT to receive a steady flow of rental income with reduced operational burdens. Key revenue streams include monthly or quarterly rent payments from its tenants, which are often structured to increase over time through fixed escalations or contingent upon tenant performance. Additionally, UHT may engage in strategic partnerships with healthcare providers to enhance its portfolio and secure favorable lease terms. The stability of its revenue is further supported by the essential nature of healthcare services, which tends to be resilient even during economic downturns.

Universal Health Realty Income Financial Statement Overview

Summary

Profitability and cash generation are generally solid (strong margins in 2022–2024; operating cash flow and free cash flow steady/strong). Offsetting this is meaningful leverage (elevated debt-to-equity and declining equity) and apparent 2025 annual data anomalies (e.g., revenue/debt shown as zero) that reduce confidence in the most recent trend.

Income Statement

From 2020–2024, revenue rose steadily (about $78.0M to $99.0M) with strong profitability: gross margin remained ~94% and net margin ranged ~16%–23% in 2022–2024. Net income improved in 2024 versus 2023 ($19.2M vs. $15.4M). However, profitability was unusually volatile in 2021 (exceptionally high margins and net income), and the 2025 annual line shows revenue and margins at zero with a -100% growth rate, suggesting data quality or comparability issues that materially cloud the latest-year trend.

Balance Sheet

The balance sheet is meaningfully levered: debt to equity was elevated in 2022–2024 (roughly 1.5x to 2.1x), which can constrain flexibility if funding costs rise. Total assets have been broadly stable (~$581M–$607M in 2021–2024). Equity has trended down since 2021 (from ~$235M to ~$180M by 2024), while returns on equity were moderate in 2022–2024 (~7.7%–10.7%). The 2025 annual snapshot shows zero debt, which is inconsistent with prior years and reduces confidence in the latest period’s leverage view.

Cash Flow

Cash generation looks solid and consistent: operating cash flow has been relatively steady (~$43M–$49M from 2022–2025), and free cash flow is strong, including a sharp rebound in 2025 ($49.1M vs. $46.9M in 2024). Free cash flow kept pace with net income in 2023–2025 (free cash flow to net income of 1.0), indicating good earnings quality in those years. A watch item is that cash flow coverage of debt is modest in 2022–2024 (low-teens), which matters given the company’s leverage profile.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	0.00	99.01M	95.58M	90.63M	84.19M
Gross Profit	0.00	93.53M	90.25M	85.53M	79.78M
EBITDA	28.86M	70.49M	65.16M	58.41M	145.45M
Net Income	17.61M	19.23M	15.40M	21.10M	109.17M
Balance Sheet
Total Assets	564.91M	580.86M	596.37M	607.54M	598.42M
Cash, Cash Equivalents and Short-Term Investments	6.69M	7.10M	8.21M	7.61M	22.50M
Total Debt	0.00	379.17M	370.41M	354.28M	340.26M
Total Liabilities	412.52M	401.32M	395.44M	378.44M	363.09M
Stockholders Equity	152.38M	179.54M	200.93M	229.10M	235.33M
Cash Flow
Free Cash Flow	49.09M	46.91M	43.47M	33.19M	34.74M
Operating Cash Flow	49.09M	46.91M	43.47M	46.80M	47.73M
Investing Cash Flow	-14.96M	-13.88M	-19.87M	-36.67M	-24.43M
Financing Cash Flow	-34.55M	-34.15M	-23.01M	-25.02M	-6.54M

Universal Health Realty Income Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 41.07
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UHT, the sentiment is Positive. The current price of 41.07 is below the 20-day moving average (MA) of 42.05, above the 50-day MA of 40.77, and above the 200-day MA of 38.92, indicating a bullish trend. The MACD of 0.98 indicates Negative momentum. The RSI at 68.31 is Neutral, neither overbought nor oversold. The STOCH value of 76.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UHT.

Universal Health Realty Income Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SILA	73 Outperform	$1.41B	42.76	2.34%	6.98%	3.74%	77.82%
LTC	69 Neutral	$1.86B	15.50	3.49%	6.70%	11.89%	-68.41%
CHCT	66 Neutral	$479.15M	210.98	0.46%	12.08%	3.40%	-240.85%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
UHT	64 Neutral	$604.33M	33.63	10.55%	7.51%	0.68%	-1.34%
GMRE	55 Neutral	$527.49M	-146.25	0.49%	10.01%	2.73%	-131.16%
DHC	54 Neutral	$1.48B	-5.37	-15.78%	0.80%	4.10%	8.96%